Concepedia

Author

Alyssa Morimoto

Roche (Switzerland)

Also Known As

A Morimoto, A. Morimoto, Alyssa M Morimoto, Alyssa M. Morimoto, Alyssa Morimoto, V Botchkarev

37

Publications

2.5K

Citations

22

H-Index

41

Concepts

All Affiliations

Roche (Switzerland)Pfizer (United States)Stanford UniversityUniversity College LondonUniversity of Michigan
AM

About

Alyssa Morimoto is an author at Roche (Switzerland) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

1.1K

2

Cell Biology

5

5

410

3

Immunology

2

2

82

4

Biostatistics

1

1

43

5

Medical Laboratory Science

1

1

43

Alyssa Morimoto

×

24

Publications

2.4K

Citations

21

H-Index

YearCitations

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

Dinesh Khanna, Christopher P. Denton, Angelika Jahreis,

The Lancet

2016

652

Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.

I. Wayne Cheney, Duane E. Johnson, M T Vaillancourt,

PubMed

1998

190

Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo‐controlled, double‐blind, dose‐escalation study

Jacqueline McBride, Jenny Jiang, Alexander R. Abbas,

Arthritis & Rheumatism

2012

183

Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE

William P. Kennedy, Romeo Maciuca, Kristen Wolslegel,

Lupus Science & Medicine

2015

150

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

David Isenberg, Richard Furie, Nicholas S. Jones,

Arthritis & Rheumatology

2021

126

Association of endogenous anti–interferon‐α autoantibodies with decreased interferon‐pathway and disease activity in patients with systemic lupus erythematosus

Alyssa Morimoto, Donna Flesher, Jihong Yang,

Arthritis & Rheumatism

2011

122

Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma

Maurizio Zangari, Elias Anaissie, Alison Stopeck,

Clinical Cancer Research

2004

116

Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase <scp>II</scp> Trial

Stanley Cohen, Katie Tuckwell, Tamiko R. Katsumoto,

Arthritis & Rheumatology

2020

113

Pointed, an ETS domain transcription factor, negatively regulates the EGF receptor pathway in <i>Drosophila</i> oogenesis

Alyssa Morimoto, Katherine C. Jordan, Kyria Tietze,

Development

1996

97

The homeobox gene mirror links EGF signalling to embryonic dorso-ventral axis formation through Notch activation

Katherine C. Jordan, Nigel Clegg, Jennifer A. Blasi,

Nature Genetics

2000

93

Page 1